No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
2 | Adherens junction 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
3 | Adipocytokine signaling pathway 3 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
4 | Adrenergic signaling in cardiomyocytes 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5 | African trypanosomiasis 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
6 | AGE-RAGE signaling pathway in diabetic complications 6 genes, 3 drugs (DrugBank) and 21 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
7 | Allograft rejection 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
8 | Alzheimer disease 7 genes, 4 drugs (DrugBank) and 61 diseases shown |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
9 | Amoebiasis 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
10 | Amphetamine addiction 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
11 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
12 | Amyotrophic lateral sclerosis (ALS) 6 genes, 4 drugs (DrugBank) and 61 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
13 | Antifolate resistance 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
14 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
15 | Apelin signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
16 | Apoptosis 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
17 | Asthma 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
18 | Autoimmune thyroid disease 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
19 | Autophagy - animal 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
20 | Autophagy - other 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
21 | Axon guidance 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
22 | B cell receptor signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
23 | Bladder cancer 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: FGFR3 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
24 | Breast cancer 3 genes, 2 drugs (DrugBank) and 11 diseases shown |
2件: FGFR1, FLT4 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
25 | C-type lectin receptor signaling pathway 9 genes, 4 drugs (DrugBank) and 61 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
26 | Calcium signaling pathway 9 genes, 6 drugs (DrugBank) and 62 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
27 | cAMP signaling pathway 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
28 | Cellular senescence 8 genes, 4 drugs (DrugBank) and 62 diseases shown |
2件: IL1A, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
29 | Central carbon metabolism in cancer 6 genes, 2 drugs (DrugBank) and 11 diseases shown |
5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
30 | cGMP-PKG signaling pathway 6 genes, 4 drugs (DrugBank) and 61 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
31 | Chagas disease (American trypanosomiasis) 7 genes, 3 drugs (DrugBank) and 26 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
32 | Chemokine signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: CCL2 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
33 | Choline metabolism in cancer 3 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
34 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
35 | Colorectal cancer 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
36 | Cytokine-cytokine receptor interaction 10 genes, 4 drugs (DrugBank) and 29 diseases shown |
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
37 | Cytosolic DNA-sensing pathway 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
38 | Dilated cardiomyopathy (DCM) 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
39 | Dopaminergic synapse 3 genes, 2 drugs (DrugBank) and 55 diseases shown |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
40 | Drug metabolism - other enzymes 2 genes, 1 drug (DrugBank) and 34 diseases shown |
2件: IMPDH1, IMPDH2 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
41 | EGFR tyrosine kinase inhibitor resistance 9 genes, 5 drugs (DrugBank) and 19 diseases shown |
5件: FGFR2, FGFR3, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
42 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 1 drug (DrugBank) and 15 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
43 | Endocrine resistance 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
44 | Endocytosis 4 genes, 2 drugs (DrugBank) and 10 diseases shown |
3件: FGFR2, FGFR3, PDGFRA |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
45 | Epstein-Barr virus infection 3 genes, 4 drugs (DrugBank) and 22 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
46 | ErbB signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
47 | Fc epsilon RI signaling pathway 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
48 | Fluid shear stress and atherosclerosis 5 genes, 3 drugs (DrugBank) and 22 diseases shown |
4件: CCL2, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
49 | Focal adhesion 5 genes, 1 drug (DrugBank) and 4 diseases shown |
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
50 | FoxO signaling pathway 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
51 | Gap junction 2 genes, 1 drug (DrugBank) and 4 diseases shown |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
52 | Gastric cancer 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: FGFR2 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
53 | Glioma 3 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
54 | Glucagon signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
55 | Glutamatergic synapse 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
56 | Graft-versus-host disease 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
57 | Growth hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
58 | Hematopoietic cell lineage 5 genes, 3 drugs (DrugBank) and 25 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
59 | Hepatitis B 4 genes, 4 drugs (DrugBank) and 22 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
60 | Hepatitis C 2 genes, 4 drugs (DrugBank) and 22 diseases shown |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
61 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
62 | Herpes simplex virus 1 infection 10 genes, 6 drugs (DrugBank) and 34 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
63 | HIF-1 signaling pathway 5 genes, 4 drugs (DrugBank) and 22 diseases shown |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
64 | Human cytomegalovirus infection 12 genes, 8 drugs (DrugBank) and 66 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: PDGFRA |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
65 | Human immunodeficiency virus 1 infection 7 genes, 5 drugs (DrugBank) and 66 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
66 | Human papillomavirus infection 4 genes, 6 drugs (DrugBank) and 29 diseases shown |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
67 | Human T-cell leukemia virus 1 infection 10 genes, 7 drugs (DrugBank) and 61 diseases shown |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
68 | Hypertrophic cardiomyopathy (HCM) 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
69 | IL-17 signaling pathway 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
70 | Inflammatory bowel disease (IBD) 7 genes, 3 drugs (DrugBank) and 26 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
71 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: IL1B |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
72 | Influenza A 9 genes, 5 drugs (DrugBank) and 27 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
73 | Insulin resistance 3 genes, 3 drugs (DrugBank) and 28 diseases shown |
2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
74 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
75 | Intestinal immune network for IgA production 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
76 | JAK-STAT signaling pathway 10 genes, 7 drugs (DrugBank) and 26 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
77 | Kaposi sarcoma-associated herpesvirus infection 10 genes, 7 drugs (DrugBank) and 63 diseases shown |
1件: IFNGR1 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
78 | Legionellosis 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
79 | Leishmaniasis 8 genes, 5 drugs (DrugBank) and 27 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
4件: IL10, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
80 | Long-term potentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
81 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
82 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
83 | Malaria 5 genes, 2 drugs (DrugBank) and 21 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
84 | MAPK signaling pathway 16 genes, 5 drugs (DrugBank) and 62 diseases shown |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
85 | Measles 5 genes, 4 drugs (DrugBank) and 15 diseases shown |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
86 | Melanoma 3 genes, 1 drug (DrugBank) and 4 diseases shown |
3件: FGFR1, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
87 | Metabolic pathways 2 genes, 1 drug (DrugBank) and 34 diseases shown |
2件: IMPDH1, IMPDH2 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
88 | MicroRNAs in cancer 4 genes, 2 drugs (DrugBank) and 11 diseases shown |
3件: FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
89 | Mineral absorption 1 gene, 1 drug (DrugBank) and 15 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
90 | mTOR signaling pathway 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
91 | Natural killer cell mediated cytotoxicity 8 genes, 5 drugs (DrugBank) and 62 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
92 | Necroptosis 7 genes, 5 drugs (DrugBank) and 27 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
93 | Neuroactive ligand-receptor interaction 3 genes, 7 drugs (DrugBank) and 53 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
D08229 |
1件: NR3C1 |
D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
D07981 |
Fluticasone |
4件: 98, 228, 299, 306 |
D01708 |
Fluticasone propionate |
4件: 98, 228, 299, 306 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
94 | NF-kappa B signaling pathway 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
95 | NOD-like receptor signaling pathway 5 genes, 4 drugs (DrugBank) and 22 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
96 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
97 | Oocyte meiosis 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
98 | Osteoclast differentiation 11 genes, 7 drugs (DrugBank) and 62 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
99 | Oxytocin signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
100 | Pancreatic cancer 2 genes, 3 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
101 | Parathyroid hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank) and 18 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
102 | Pathogenic Escherichia coli infection 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
103 | Pathways in cancer 13 genes, 7 drugs (DrugBank) and 26 diseases shown |
6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
104 | PD-L1 expression and PD-1 checkpoint pathway in cancer 10 genes, 6 drugs (DrugBank) and 62 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
105 | Pertussis 5 genes, 2 drugs (DrugBank) and 21 diseases shown |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
106 | Phospholipase D signaling pathway 3 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
2件: PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
107 | PI3K-Akt signaling pathway 13 genes, 6 drugs (DrugBank) and 22 diseases shown |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
108 | Prion diseases 3 genes, 1 drug (DrugBank) and 10 diseases shown |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
109 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
110 | Prostate cancer 5 genes, 2 drugs (DrugBank) and 11 diseases shown |
4件: FGFR1, FGFR2, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
111 | Proteasome 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: PSMB5 |
D03150 |
Bortezomib |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
112 | Proteoglycans in cancer 4 genes, 4 drugs (DrugBank) and 28 diseases shown |
2件: FGFR1, KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
113 | Purine metabolism 2 genes, 1 drug (DrugBank) and 34 diseases shown |
2件: IMPDH1, IMPDH2 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
114 | Rap1 signaling pathway 8 genes, 1 drug (DrugBank) and 4 diseases shown |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
115 | Ras signaling pathway 8 genes, 1 drug (DrugBank) and 4 diseases shown |
8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
116 | Regulation of actin cytoskeleton 5 genes, 1 drug (DrugBank) and 4 diseases shown |
5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
117 | Regulation of lipolysis in adipocytes 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
118 | Renin secretion 6 genes, 4 drugs (DrugBank) and 61 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
119 | Rheumatoid arthritis 6 genes, 3 drugs (DrugBank) and 22 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
120 | RIG-I-like receptor signaling pathway 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
121 | Salivary secretion 1 gene, 2 drugs (DrugBank) and 14 diseases shown |
1件: ADRB2 |
D01373 |
Formoterol |
4件: 85, 228, 299, 306 |
D05277 |
D07990 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
122 | Salmonella infection 5 genes, 2 drugs (DrugBank) and 15 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
123 | Shigellosis 3 genes, 3 drugs (DrugBank) and 28 diseases shown |
2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
124 | Signaling pathways regulating pluripotency of stem cells 5 genes, 3 drugs (DrugBank) and 7 diseases shown |
3件: FGFR1, FGFR2, FGFR3 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
125 | Sphingolipid signaling pathway 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
126 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
127 | Systemic lupus erythematosus 2 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
128 | T cell receptor signaling pathway 7 genes, 4 drugs (DrugBank) and 61 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
129 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
130 | Th1 and Th2 cell differentiation 10 genes, 6 drugs (DrugBank) and 56 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
131 | Th17 cell differentiation 13 genes, 8 drugs (DrugBank) and 63 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
132 | Thermogenesis 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: FGFR1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
133 | Thyroid hormone signaling pathway 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
134 | TNF signaling pathway 5 genes, 2 drugs (DrugBank) and 21 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
135 | Toll-like receptor signaling pathway 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
136 | Toxoplasmosis 6 genes, 5 drugs (DrugBank) and 27 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
137 | Transcriptional misregulation in cancer 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: FLT1 |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
138 | Tuberculosis 15 genes, 8 drugs (DrugBank) and 63 diseases shown |
2件: IFNGR1, IFNGR2 |
D00747 |
Interferon gamma-1b |
7件: 65, 85, 90, 228, 299, 301, 326 |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
2件: JAK1, JAK2 |
D09959 |
Ruxolitinib |
1件: 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
139 | Type I diabetes mellitus 4 genes, 2 drugs (DrugBank) and 21 diseases shown |
3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
140 | Type II diabetes mellitus 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
141 | VEGF signaling pathway 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: KDR |
D10481 |
Nintedanib |
4件: 51, 85, 89, 228 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
142 | Viral carcinogenesis 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: JAK1 |
D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
D09959 |
Ruxolitinib |
1件: 228 |
143 | Viral protein interaction with cytokine and cytokine receptor 6 genes, 3 drugs (DrugBank) and 25 diseases shown |
4件: CCL2, IL10, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: IL2RA |
D03058 |
Basiliximab |
7件: 2, 50, 65, 66, 97, 222, 228 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
144 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
145 | Yersinia infection 5 genes, 2 drugs (DrugBank) and 21 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |